• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉输注链激酶(s)后急性心肌梗死(AMI)的心前区心电图映射

Precordial ECG mapping in acute myocardial infarction (AMI) after intravenous infusion of streptokinase (s).

作者信息

Babalis D C, Boutos G N, Iliodromitis E K, Trovas A K, Vorides E M

机构信息

2nd Cardiology Department, Evangelismos Hospital, Athens, Greece.

出版信息

Angiology. 1989 Dec;40(12):1040-7. doi: 10.1177/000331978904001204.

DOI:10.1177/000331978904001204
PMID:2596737
Abstract

Repeated precordial ECG mapping (42 leads) and CK-MB serum measurements were done in 40 patients with anterior and/or anterolateral acute myocardial infarction. Twenty patients serving as controls, were treated with routine anticoagulant therapy. In 20 patients (the s group), randomly selected, a short-term IV infusion of 1,500,000 IU streptokinase was administered and followed by the same anticoagulant treatment as in controls. Ten subjects from each group underwent coronary arteriography one month later. From the analysis of ECG mapping the number of leads (N) and the sum of measurements (sigma) for each parameter were calculated. Before treatment there were no significant differences for all measured parameters between the two groups of patients. Seven days later, ST elevations were statistically different for NST and sigma ST with lower values for the s group. Higher values for NR and sigma R were also noted in this group. No statistically significant difference was found for NQ and sigma Q. CK-MB curve showed an earlier peak in the s group than in the control group. Five patients from the s group showed a patency of the infarct-related vessel. In conclusion, the results of this study show that patients receiving s have a significant benefit with ECG improvement. On the other hand, the CK-MB curve indicates an eventual recanalization to a certain degree in the obstructed coronary artery, which is the final goal.

摘要

对40例急性前壁和/或前侧壁心肌梗死患者进行了重复的心前区心电图标测(42导联)和血清肌酸激酶同工酶(CK-MB)测定。20例患者作为对照组,接受常规抗凝治疗。随机选取20例患者(s组),静脉短期输注150万国际单位链激酶,随后给予与对照组相同的抗凝治疗。每组10名受试者在1个月后接受冠状动脉造影。通过对心电图标测的分析,计算每个参数的导联数(N)和测量值总和(σ)。治疗前,两组患者所有测量参数均无显著差异。7天后,s组的NST和σST的ST段抬高在统计学上有差异,s组的值较低。该组的NR和σR值也较高。NQ和σQ未发现统计学上的显著差异。CK-MB曲线显示s组比对照组出现峰值更早。s组有5例梗死相关血管通畅。总之,本研究结果表明,接受s治疗的患者在心电图改善方面有显著益处。另一方面,CK-MB曲线表明阻塞的冠状动脉最终在一定程度上实现了再通,这是最终目标。

相似文献

1
Precordial ECG mapping in acute myocardial infarction (AMI) after intravenous infusion of streptokinase (s).静脉输注链激酶(s)后急性心肌梗死(AMI)的心前区心电图映射
Angiology. 1989 Dec;40(12):1040-7. doi: 10.1177/000331978904001204.
2
ECG and enzymatic indicators of therapeutic success after intravenous streptokinase for acute myocardial infarction--a pilot study.
J Pak Med Assoc. 1992 Dec;42(12):288-90.
3
ECG and enzymatic indicators of therapeutic success after intravenous streptokinase for acute myocardial infarction.静脉注射链激酶治疗急性心肌梗死后治疗成功的心电图及酶学指标
Am Heart J. 1990 Sep;120(3):503-9. doi: 10.1016/0002-8703(90)90002-f.
4
Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase.冠状动脉内溶栓治疗后血清心肌酶的时间进程。肌酸激酶、肌酸激酶MB同工酶、乳酸脱氢酶和血清谷草转氨酶。
Arch Intern Med. 1985 Sep;145(9):1596-600.
5
[Indirect criteria of coronary reperfusion and permeability in patients with acute myocardial infarction who have received thrombolytic therapy].[急性心肌梗死接受溶栓治疗患者冠状动脉再灌注及通透性的间接标准]
Rev Port Cardiol. 1991 Mar;10(3):229-35.
6
[The Italian Group for the Study of Streptokinase in Myocardial Infarct: Study of electrocardiographic changes].
G Ital Cardiol. 1987 Jan;17(1):57-62.
7
A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.急性心肌梗死静脉注射链激酶前瞻性试验(I.S.A.M.)。21天时的死亡率、发病率和梗死面积。
N Engl J Med. 1986 Jun 5;314(23):1465-71. doi: 10.1056/NEJM198606053142301.
8
A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.一个评分可预测急性心肌梗死溶栓治疗后再灌注失败。
Am Heart J. 2003 Mar;145(3):508-14. doi: 10.1067/mhj.2003.184.
9
[The Italian Group for the Study of Streptokinase in Myocardial Infarct: Changes in surface cardiac potentials. Study with chest electromaps].[意大利心肌梗死链激酶研究小组:心脏表面电位变化。胸部心电地图研究]
G Ital Cardiol. 1987 Jan;17(1):63-72.
10
Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.急性心肌梗死中加速输注链激酶可使梗死相关动脉获得更好的心肌梗死溶栓治疗(TIMI)血流分级。
Indian Heart J. 2000 Jan-Feb;52(1):40-4.